Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 4
2013 2
2014 2
2015 3
2016 5
2017 6
2019 2
2020 3
2021 4
2022 4
2023 3
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis.
Al-Janabi A, Alabas OA, Yiu ZZN, Foulkes AC, Eyre S, Khan AR, Reynolds NJ, Smith CH, Griffiths CEM, Warren RB; BADBIR Study Group. Al-Janabi A, et al. Among authors: alabas oa. JAMA Dermatol. 2024 Jan 1;160(1):71-79. doi: 10.1001/jamadermatol.2023.4846. JAMA Dermatol. 2024. PMID: 38055239 Free PMC article.
Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study.
Motedayen Aval L, Yiu ZZN, Alabas OA, Griffiths CEM, Reynolds NJ, Hampton PJ, Smith CH, Warren RB; BADBIR Study Group. Motedayen Aval L, et al. Among authors: alabas oa. J Eur Acad Dermatol Venereol. 2025 Oct;39(10):1785-1795. doi: 10.1111/jdv.20739. Epub 2025 May 29. J Eur Acad Dermatol Venereol. 2025. PMID: 40439435 Free PMC article.
Understanding the gender-pain gap.
Tashani OA, Alabas OA, Johnson MI. Tashani OA, et al. Among authors: alabas oa. Pain Manag. 2012 Jul;2(4):315-7. doi: 10.2217/pmt.12.34. Pain Manag. 2012. PMID: 24654714 No abstract available.
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohort.
Alabas OA, Evans I, Mcelhone K, Yiu ZZN, Reynolds NJ, Laws P, Bewley A, Smith CH, Lunt M, Griffiths CEM, Warren RB; BADBIR Study Group. Alabas OA, et al. Clin Exp Dermatol. 2025 Sep 25;50(10):1995-2006. doi: 10.1093/ced/llaf224. Clin Exp Dermatol. 2025. PMID: 40402160
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis.
Douroudis K, Ramessur R, Barbosa IA, Baudry D, Duckworth M, Angit C, Capon F, Chung R, Curtis CJ, Di Meglio P, Goulding JMR, Griffiths CEM, Lee SH, Mahil SK, Parslew R, Reynolds NJ, Shipman AR, Warren RB, Yiu ZZN, Simpson MA, Barker JN, Dand N, Smith CH; BADBIR; BSTOP Study Groups. Douroudis K, et al. J Invest Dermatol. 2022 Jun;142(6):1617-1628.e10. doi: 10.1016/j.jid.2021.08.446. Epub 2021 Nov 10. J Invest Dermatol. 2022. PMID: 34767815 Free article.
37 results